#2026/202Ulusal Sağlık ve Bakım Mükemmeliyeti Enstitüsü (Değişiklik) Yönetmelikleri 2026
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The 2026 amendments give the Secretary of State the authority to direct NICE on how to set cost-effectiveness thresholds for health technologies. This affects how NICE evaluates new health treatments and technologies for the NHS. Ultimately, it may influence decisions on which health technologies are funded.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Introduces a power for the Secretary of State to direct NICE.
- Affects the cost-effectiveness threshold NICE uses.
- Applies to technology appraisals under existing regulations.
Obligations
What this law requires
NICE must apply cost-effectiveness thresholds as directed by the Secretary of State when conducting technology appraisals under regulation 7 of the 2013 Regulations
NICE must apply cost-effectiveness thresholds as directed by the Secretary of State when appraising highly specialised health technologies under regulation 8 of the 2013 Regulations
The Secretary of State has authority to issue directions to NICE regarding which cost-effectiveness threshold to apply to health technologies during appraisals